Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101
Ovid Therapeutics Announces Initiation of Two Phase 2 Clinical Trials of OV935/TAK-935 for Pediatric Patients with Rare Epilepsies
SAGA Metals Completes Phase 1 & Commences Phase 2 of Drilling at Radar Project in Labrador-Confirms Extensive Oxide Mineralization Over 1.5 Km & Provides Corporate Update
Nine Mile Metals Announces Completion of DDH WD-25-02 and Continues to Confirm (2) Zones of Copper Rich VMS Mineralization at the Wedge Project Drill Program
